SAN DIEGO, CA, May possibly 23, 2022 (Globe NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-at any time publicly traded cannabis corporation in the United States that introduced the world’s 1st-ever hashish-derived nutraceutical products, models, and offer chain, declared now that its subsidiary HempMeds® Brasil was showcased in Forbes on its recent successes.
The short article titled, “The Steps of Hashish in Brazil” specifics how HempMeds® Brasil has grown 50% 12 months about year considering that setting up functions in 2014 and how the corporation has collaborated on importing additional than 140,000 hashish-derived items for Brazilian citizens.
“We are energized that we have been provided the opportunity to share our message with the public and proceed to attain far more prospects every day,” stated HempMeds® Brasil Executive Director Matheus Patelli. “Articles like this are terrific for the cannabis marketplace simply because they enable carry exposure to companies that are undertaking excellent matters to support assist the health and fitness and wellness of the persons and enable lessen the stigma similar to hashish solutions.”
It is also crucial to be aware that in the very first quarter of 2022, HempMeds® Brasil grew 75.8% quicker than the overall cannabidiol (CBD) marketplace. This milestone can be attributed to the subsidiary’s large community of doctors and clinical industry experts and the trustworthiness of its high-good quality CBD products.
“It is very worthwhile to see our company operation in Brazil expand and get the consideration it deserves,” explained Healthcare Cannabis, Inc. CEO Blake Schroeder. “Brazil has been an significant component of our intercontinental growth and we are proud of the legacy of totally free entry that we have established in Brazil and all-around the environment that has impacted life and pushed constructive global adjust.”
To learn a lot more about HempMeds® Brasil, you should visit www.hempmeds.com.br.
About HempMeds® Brasil
HempMeds® Brasil was the very first company to acquire approval from the Countrywide Sanitary Surveillance Agency (Anvisa) to import a merchandise primarily based on cannabidiol, a substance derived from hemp, a plant of the genus Hashish. At present, it is authorized to provide its items, which help in the manage of ailments these types of as epilepsy, Parkinson’s, persistent soreness and several sclerosis, under medical prescription. For these indications, the products can be backed by the Brazilian govt. HempMeds® Brasil is working on additional approvals for other indications. www.hempmeds.com.br.
About Clinical Cannabis, Inc.
We are a organization of firsts®. Health care Cannabis, Inc. (MJNA) is a cannabis organization with a few distinctive enterprise models in the non-psychoactive cannabinoid place: a global portfolio of cannabinoid-centered nutraceutical brands led by Kannaway® and HempMeds® a pioneer in sourcing the optimum-high-quality authorized non-psychoactive hashish goods derived from industrial hemp and a cannabinoid-based clinical study and botanical drug development sector led by its pharmaceutical financial commitment companies and companions together with AXIM® Biotechnologies, Inc. and Neuropathix. Health-related Marijuana, Inc. was named a top rated CBD producer by CNBC. Professional medical Marijuana, Inc. was also the first corporation to get historic import permits for CBD products and solutions from the governments of Brazil, Mexico, Argentina, and Paraguay and is a chief in the advancement of international markets. The company’s flagship product Authentic Scientific Hemp Oil has been utilised in a number of prosperous clinical reports during Mexico and Brazil to understand its basic safety and efficacy.
Health-related Marijuana, Inc.’s headquarters is in San Diego, California, and extra facts is obtainable at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Health care Cannabis, Inc.’s company movie, click in this article.
This push release may perhaps consist of sure ahead-on the lookout statements and details, as defined inside the that means of Area 27A of the Securities Act of 1933 and Portion 21E of the Securities Exchange Act of 1934, and is subject to the Protected Harbor created by those sections. This materials consists of statements about anticipated foreseeable future occasions and/or fiscal success that are forward-seeking in character and issue to hazards and uncertainties. This sort of forward-wanting statements by definition require challenges, uncertainties and other factors, which could induce the precise benefits, general performance or achievements of Medical Cannabis, Inc. to be materially different from the statements made herein.
Foods AND DRUG ADMINISTRATION (Food and drug administration) DISCLOSURE
These statements have not been evaluated by the Foods and Drug Administration. This product is not supposed to diagnose, take care of, treatment, or avoid any condition.
Professional medical Marijuana, Inc. does not provide or distribute any goods that are in violation of the United States Controlled Substances Act.
Trader Relations Make contact with:
P. (858) 283-4016